65 I B, drugs, pharmaceuticals, & hematology related products, FSS contract award

Active Awarded Last action

Contract number
36F79725D0061
Awardee
Awarding agency
Task orders
11

Award facts

Opportunity
Last date to order 34% complete
IDV ceiling
$33,573,490.00
Award type
Multiple award
Who can order
All agencies
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Fixed Price with Economic Price Adjustment

Award details come from SAM.gov/FPDS.

About this IDV

GSA issued a Federal Supply Schedule contract to Helsinn Therapeutics (U.S.), Inc. under the Pharmaceuticals and Drugs schedule (FSS-61-IB) on March 1, 2025, with a ceiling value of $33,573,490 and a performance period through February 28, 2030. The contract carries a permanent price reduction and operates without set-aside.

Place of performance is Iselin, New Jersey. The schedule supports multi-agency ordering across federal healthcare systems, including the Department of Veterans Affairs, correctional facilities, and federal medical centers.

Recent delivery orders issued under this schedule demonstrate active customer engagement. Federal Correctional Institution Fort Worth has placed recurring monthly orders for VALCHLOR gel (0.01265% topical formulation) at $5,984.59 per order, with nine documented awards between February and October 2026. Federal Medical Center Carswell issued a $5,984.59 delivery order on January 31, 2026, with completion by February 24, 2026. Veterans Integrated Service Network 5 placed a $14,559.84 delivery order on August 6, 2025, with completion through August 8, 2025.

Helsinn Therapeutics specializes in oncology pharmaceuticals, with VALCHLOR gel as its primary federal product. The product treats cutaneous T-cell lymphoma and is supplied to federal correctional facilities and VA medical centers nationwide. The vendor operates as a prime contractor only, with no subcontracting relationships disclosed.

A related single-award Blanket Purchase Agreement under the same schedule was awarded March 12, 2025, with a ceiling of $8,338,904.40 and completion through March 11, 2027.

Task orders

Show all 11

IDV awards

IDV Agency Ceiling Awarded
36E79725A0008 New BPA for valchlor National Acquisition Center (VA) $8,338,904

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00010 $0
Supplemental Agreement for work within scope P00009 $0
Supplemental Agreement for work within scope P00008 · Permanent price reduction $0
Supplemental Agreement for work within scope P00007 · Product deletion $0
Supplemental Agreement for work within scope P00006 · Price decrease $0
Supplemental Agreement for work within scope P00005 · 2026 public law update $0
Supplemental Agreement for work within scope P00004 · OGA only PPR $0
Supplemental Agreement for work within scope P00003 · PPR OGA only $0
Supplemental Agreement for work within scope P00002 $0
Supplemental Agreement for work within scope P00001 · Price decrease $0
Original award $0
Show all 11

Quick answers

Who was awarded contract 36F79725D0061?

36F79725D0061 was awarded to Helsinn Therapeutics (U.s.), Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on March 1, 2025.

How much is contract 36F79725D0061 worth?

36F79725D0061's own ceiling is $33,573,490.

How many orders have been placed under contract 36F79725D0061?

11 orders have been placed under 36F79725D0061, the latest on November 1, 2026.

Who can order from contract 36F79725D0061?

36F79725D0061 is a multiple award federal supply schedule. All agencies can place orders on it.

Is contract 36F79725D0061 part of a contract vehicle?

Yes. 36F79725D0061 is part of Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36F79725D0061 competed?

The extent of competition for 36F79725D0061 was full and open competition.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV